Makoto Ohori
Direktor/Vorstandsmitglied bei Axial Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sakae Asanuma | M | 57 |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California.
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 6 Jahre |
| Ronald Renaud | M | 55 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 7 Jahre |
| A. Stewart Campbell | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 8 Jahre |
| Kentaro Yoshimatsu | M | 70 |
Rin Institute, Inc.
 Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | 8 Jahre |
| Mikio Kawahara | M | - |
UTokyo Innovation Platform Co.,Ltd.
 UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 8 Jahre |
| Sarkis K. Mazmanian | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| James Blair | M | 84 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Kosuke Ueda | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 7 Jahre |
| Kazuhiko Kakehi | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 8 Jahre |
| Shoichiro Fukushima | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 6 Jahre |
| Kei Furukawa | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 5 Jahre |
| Takahiro Mizumoto | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 7 Jahre |
| Atsuhiro Bingo | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | - |
| Chris Meyer | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Yasuhiro Matsumura | M | - |
Rin Institute, Inc.
Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
| Steven Opal | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Akihiko Asami | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 6 Jahre |
| Masayoshi Miyanaga | M | 66 |
Rin Institute, Inc.
Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
| Akira Morita | M | 73 |
University of Tokyo
| 30 Jahre |
| Scott Brun | M | 56 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 4 Jahre |
| Richard H. Aldrich | M | 69 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Suguru Mima | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 3 Jahre |
| Hiroko Kimura | M | - |
Rin Institute, Inc.
Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Rin Institute, Inc. is a company based in Tokyo, Japan that was founded in 2016 by Kentaro Yoshimatsu. The Japanese company's website simply states that it is "just another WordPress site." | - |
| Eric Forquenot de la Fortelle | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 5 Jahre |
| Katsuhiko Oizumi | M | - |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | 8 Jahre |
| Jeffrey E. Young | M | 51 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Sarah J. Meibusch | F | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 3 Jahre |
| Nora Frey | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 3 Jahre |
| Federico Bolognani | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yutaka Matsuo | M | 49 |
University of Tokyo
| 9 Jahre |
| Nobuaki Shindoh | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 2 Jahre |
| Jian Nian Yao | M | 70 |
University of Tokyo
| 4 Jahre |
| Ken Shimokawa | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 3 Jahre |
| Hirofumi Ono | M | 49 |
University of Tokyo
| 8 Jahre |
| Hideaki Yajima | M | - |
University of Tokyo
| 6 Jahre |
| Seong-Gi Park | M | 58 |
University of Tokyo
| 5 Jahre |
| Jeong Lee | M | 72 |
University of Tokyo
| 5 Jahre |
| Eihito Tamura | M | - |
University of Tokyo
| 4 Jahre |
| Qing Huang | M | 61 |
University of Tokyo
| 1 Jahre |
| Kazunori kakiuchi | M | 54 |
University of Tokyo
| 3 Jahre |
| Norihiro Suzuki | M | 62 |
University of Tokyo
| 3 Jahre |
| Hiroaki Kumamoto | M | 55 |
University of Tokyo
| 4 Jahre |
| Shu Ting Zhang | M | 65 |
University of Tokyo
| 3 Jahre |
| Shigeru Asaba | M | 63 |
University of Tokyo
| 3 Jahre |
| Satoshi Niibe | M | 58 |
University of Tokyo
| 1 Jahre |
| Yuriko Kato | F | 50 |
University of Tokyo
| 4 Jahre |
| Masaki Yano | M | - |
University of Tokyo
| 4 Jahre |
| Shunichiro Matsumoto | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 4 Jahre |
| Ryosuke Munakata | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 2 Jahre |
| Shinjiro Uchida | M | - |
University of Tokyo
| 4 Jahre |
| Koji Kato | M | - |
University of Tokyo
| 4 Jahre |
| Yoshinori Inazumi | M | 54 |
University of Tokyo
| 4 Jahre |
| Hiroshi Baba | M | - |
University of Tokyo
| 4 Jahre |
| Kato Kazuma | M | - |
University of Tokyo
| 4 Jahre |
| Tetsuya Kojima | M | 54 |
University of Tokyo
| 4 Jahre |
| Kyuichi Fukumoto | M | 53 |
University of Tokyo
| 3 Jahre |
| Yinhai Wang | M | - |
University of Tokyo
| 3 Jahre |
| Tsune Shirota | M | - |
University of Tokyo
| - |
| Hikaru Saito | M | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 5 Jahre |
| Soichiro Yamaguchi | M | 55 |
University of Tokyo
| 4 Jahre |
| Takashi Takeuchi | M | 52 |
University of Tokyo
| 4 Jahre |
| Kyoko Hattori | M | 49 |
University of Tokyo
| 4 Jahre |
| Shinichiro Suzuki | M | 53 |
University of Tokyo
| 4 Jahre |
| Kenji Toyota | M | - |
University of Tokyo
| 3 Jahre |
| Chihiro Hosoya | F | - |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | 2 Jahre |
| Hisao Takahashi | M | - |
University of Tokyo
| 4 Jahre |
| Wang Rui | M | 52 |
University of Tokyo
| 4 Jahre |
| Chang Ming Zhao | M | - |
University of Tokyo
| 1 Jahre |
| Chang-Hai Tsai | M | 74 |
University of Tokyo
| 3 Jahre |
| Junichi Hirao | M | - |
University of Tokyo
| 4 Jahre |
| Takao Iwayanagi | M | - |
University of Tokyo
| 1 Jahre |
| Shuichi Takayama | M | 74 |
University of Tokyo
| 1 Jahre |
| A. B. M. Harun-ur-Rashid | M | - |
University of Tokyo
| 3 Jahre |
| Sachiko Okada | F | - |
University of Tokyo
| 4 Jahre |
| Nobiru Adachi | M | 66 |
University of Tokyo
| 2 Jahre |
| Masaki Hiraga | M | 49 |
University of Tokyo
| 4 Jahre |
| Katsumi Emura | M | 66 |
University of Tokyo
| 3 Jahre |
| Hiroaki Nakai | M | 51 |
University of Tokyo
| 4 Jahre |
| Keiji Hatano | M | - |
University of Tokyo
| 4 Jahre |
| Go Nakayama | M | 48 |
University of Tokyo
| 4 Jahre |
| Shinichi Uzawa | M | 50 |
University of Tokyo
| 4 Jahre |
| Kumi Arakane | M | 67 |
University of Tokyo
| 3 Jahre |
| Noboru Kashiwagi | M | 82 |
University of Tokyo
| 10 Jahre |
| Hiromichi Kimura | M | 73 |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | - |
| Nobumasa Saeki | M | 54 |
University of Tokyo
| 4 Jahre |
| Jong-Gyu Hwang | M | 53 |
University of Tokyo
| 3 Jahre |
| Tomohiro Fujita | M | 51 |
University of Tokyo
| 4 Jahre |
| Masa Hosomizu | M | - |
University of Tokyo
| 4 Jahre |
| Yoichiro Hirai | M | 49 |
University of Tokyo
| 4 Jahre |
| Mao Wu Guo | M | 64 |
University of Tokyo
| 3 Jahre |
| Tae Yamaura | F | - |
University of Tokyo
| 4 Jahre |
| Katsutoshi Mitsugi | M | 49 |
University of Tokyo
| 4 Jahre |
| Jin Akiyama | M | 53 |
University of Tokyo
| 4 Jahre |
| Yoshio Hirako | M | - |
University of Tokyo
| 3 Jahre |
| Tetsuo Ito | M | 48 |
University of Tokyo
| 4 Jahre |
| Chikafumi Yokoyama | M | 56 |
University of Tokyo
| 3 Jahre |
| Yuji Matsuda | M | 62 |
University of Tokyo
| 3 Jahre |
| Hiroshi Kaneko | M | 60 |
University of Tokyo
| 3 Jahre |
| Hiroshi Fujiwara | M | 69 |
University of Tokyo
| 3 Jahre |
| Riichiro Osawa | M | 53 |
University of Tokyo
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Japan | 79 | 79,00% |
| Vereinigte Staaten | 21 | 21,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Makoto Ohori
- Persönliches Netzwerk
